Literature DB >> 12643110

Management of the insulin resistance syndrome.

C Desouza1, L Gilling, V Fonseca.   

Abstract

The insulin resistance syndrome (IRS) is a common disorder, which has important clinical implications. It is a cluster of cardiovascular risk factors that include obesity, hypertension, dyslipidemia, glucose intolerance, and type 2 diabetes mellitus. Lifestyle modifications and insulin sensitizers are among the several therapeutic strategies available for the treatment of the IRS. Optimal treatment will not only improve glycemic control, but may also significantly lower cardiovascular disease.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 12643110     DOI： 10.1007/s11892-001-0026-6

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


  44 in total

Review 1.  Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus.

Authors:  P R Shepherd; B B Kahn
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245

Review 2.  Obesity and insulin resistance.

Authors:  B B Kahn; J S Flier
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 3.  Obesity, insulin, sex steroids and ovulation.

Authors:  J E Nestler
Journal:  Int J Obes Relat Metab Disord       Date:  2000-06

Review 4.  Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

Authors:  A Carr; K Samaras; D J Chisholm; D A Cooper
Journal:  Lancet       Date:  1998-06-20       Impact factor: 79.321

5.  The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.

Authors:  K Higashiura; N Ura; T Takada; Y Li; T Torii; N Togashi; M Takada; H Takizawa; K Shimamoto
Journal:  Am J Hypertens       Date:  2000-03       Impact factor: 2.689

6.  Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women.

Authors:  R V Dvorak; W F DeNino; P A Ades; E T Poehlman
Journal:  Diabetes       Date:  1999-11       Impact factor: 9.461

7.  Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes.

Authors:  G W Cline; K F Petersen; M Krssak; J Shen; R S Hundal; Z Trajanoski; S Inzucchi; A Dresner; D L Rothman; G I Shulman
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245

8.  Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

Authors:  V Fonseca; J Rosenstock; R Patwardhan; A Salzman
Journal:  JAMA       Date:  2000-04-05       Impact factor: 56.272

9.  Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

Authors:  H O Steinberg; H Chaker; R Leaming; A Johnson; G Brechtel; A D Baron
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension.

Authors:  C L Gaboury; D C Simonson; E W Seely; N K Hollenberg; G H Williams
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808
View more
  4 in total

1.  Tissue-specific difference in the molecular mechanisms for the development of acute insulin resistance after injury.

Authors:  Li Li; LaWanda H Thompson; Ling Zhao; Joseph L Messina
Journal:  Endocrinology       Date:  2008-09-18       Impact factor: 4.736

2.  Impact of acute psychological stress on cardiovascular risk factors in face of insulin resistance.

Authors:  Kristian T Jones; Richard C Shelton; Jun Wan; Li Li
Journal:  Stress       Date:  2016-09-20       Impact factor: 3.493

3.  Impact of Sleep and Circadian Disruption on Energy Balance and Diabetes: A Summary of Workshop Discussions.

Authors:  Deanna M Arble; Joseph Bass; Cecilia Diniz Behn; Matthew P Butler; Etienne Challet; Charles Czeisler; Christopher M Depner; Joel Elmquist; Paul Franken; Michael A Grandner; Erin C Hanlon; Alex C Keene; Michael J Joyner; Ilia Karatsoreos; Philip A Kern; Samuel Klein; Christopher J Morris; Allan I Pack; Satchidananda Panda; Louis J Ptacek; Naresh M Punjabi; Paolo Sassone-Corsi; Frank A Scheer; Richa Saxena; Elizabeth R Seaquest; Matthew S Thimgan; Eve Van Cauter; Kenneth P Wright
Journal:  Sleep       Date:  2015-12-01       Impact factor: 5.849

Review 4.  Acute insulin resistance following injury.

Authors:  Li Li; Joseph L Messina
Journal:  Trends Endocrinol Metab       Date:  2009-10-01       Impact factor: 12.015
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.